Not All Critically Ill Obese Patients Are the Same: The Influence of Prior Comorbidities

Table 4

Baseline biomarkers measurements.

Biomarkers	Units	0-1 co-morbidity (𝑛=38)		2 or more co-morbidities (𝑛=145)		P values
D-dimer	mg/L	3.2 [1.1 to 6.9]	𝑛=37	4.2 [1.8 to 9.7]	𝑛=142	0.26
Protein C	%	71.9 [46.7 to 103.4]	𝑛=37	70.8 [49.0 to 101.9]	𝑛=143	0.93
Antithrombin	%	69.0 [50.7 to 83.5]	𝑛=37	64.0 [48.8 to 80.5]	𝑛=143	0.39
Procalcitionin	ng/mL	1.0 [0.3 to 6.3]	𝑛=36	1.1 [0.4 to 5.6]	𝑛=143	0.93
CRP	mg/L	95.5 [53.0 to 199.0]	𝑛=36	106.5 [61.0 to 185.5]	𝑛=144	0.83
Fibrinogen	mg/dL	428.0 [279.7 to 596.2]	𝑛=37	394.1 [290.0 to 555.3]	𝑛=145	0.77
IL-6	pg/mL	55.4 [39.5 to 124.2]	𝑛=36	66.4 [28.3 to 226.6]	𝑛=143	0.58
Triglycerides	mmol/L	1.0 [0.6 to 1.6]	𝑛=36	1.3 [0.9 to 1.8]	𝑛=142	0.11
Cholesterol	mmol/L	2.5 [1.8 to 3.5]	𝑛=36	2.3 [1.8 to 3.4]	𝑛=143	0.54
HDL-Cholesterol	mmol/L	0.7 [0.4 to 0.9]	𝑛=36	0.7 [0.5 to 0.9]	𝑛=143	0.99
LDL-Cholesterol	mmol/L	1.5 [0.8 to 2.3]	𝑛=36	1.1 [0.6 to 2.0]	𝑛=142	0.19